Full Text View
Tabular View
No Study Results Posted
Related Studies
Trial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With Avelox (SPEED)
This study has been completed.
Study NCT00668304   Information provided by Bayer

First Received on April 25, 2008.   Last Updated on June 19, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Maxillary Sinusitis
Additional conditions recognized in this trial
Sinusitis
More general conditions related to this trial
Nose Diseases
Otorhinolaryngologic Diseases
Paranasal Sinus Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Interventions listed in this trial
Avelox (Moxifloxacin, BAY12-8039)
Additional drug interventions recognized in this trial
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
More general drug interventions related to this trial
Anti-Infective Agents
Contraceptive Agents
Contraceptive Agents, Female
Contraceptives, Oral
Contraceptives, Oral, Combined
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Bayer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services